Operating income · 2011–2025
Emergent Biosolutions operating income
$100M+$209M · FY2025
Emergent Biosolutions (EBS) reported $100M in operating income for fiscal 2025, +$209M from the year before.
| Fiscal year | Operating income | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $100M | +$209M | Open → |
| FY20242024-12-31 | −$109M | +$618M | Open → |
| FY20232023-12-31 | −$726M | −$556M | Open → |
| FY20222022-12-31 | −$170M | −$511M | Open → |
| FY20212021-12-31 | $341M | −22.1% | Open → |
| FY20202020-12-31 | $439M | +284.3% | Open → |
| FY20192019-12-31 | $114M | +27.1% | Open → |
| FY20182018-12-31 | $89.8M | −27.8% | Open → |
| FY20172017-12-31 | $124M | +17.8% | Open → |
| FY20162016-12-31 | $106M | −25.4% | Open → |
| FY20152015-12-31 | $142M | +58.7% | Open → |
| FY20142014-12-31 | $89.2M | +108.4% | Open → |
| FY20132013-12-31 | $42.8M | +42.8% | Open → |
| FY20122012-12-31 | $30.0M | −6.6% | Open → |
| FY20112011-12-31 | $32.1M | — | Open → |
Operating income — Operating income is profit from the core business before interest and tax. It strips out financing decisions, so it compares operations rather than balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +8.5%
Operating income at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions operating income |url=https://companiesranked.com/en/company/emergent-biosolutions/operating-income |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions operating income. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/operating-incomeBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-operating-income-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions operating income}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/operating-income}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001367644-26-000015 · February 27, 2026
{{cite web |title=Emergent Biosolutions operating income — 10-K (0001367644-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1367644/000136764426000015/ebs-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.